The Heregulin/Human Epidermal Growth Factor Receptor as a New Growth Factor System in Melanoma with Multiple Ways of Deregulation
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (4) , 802-812
- https://doi.org/10.1046/j.1523-1747.2003.12522.x
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Structure of the Extracellular Region of HER3 Reveals an Interdomain TetherScience, 2002
- The Transmembrane Heregulin Precursor Is Functionally ActiveJournal of Biological Chemistry, 2001
- Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector ProteinsJournal of Biological Chemistry, 2001
- Oncogenic kinase signallingNature, 2001
- Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferationOncogene, 2001
- The transcription factor Sox10 is a key regulator of peripheral glial developmentGenes & Development, 2001
- Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cellsOncogene, 1999
- The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitorProceedings of the National Academy of Sciences, 1999
- FGF Expression Allows Nevus Cells to Survive in Three-Dimensional Collagen Gel Under Conditions that Induce Apoptosis in Normal Human MelanocytesJournal of Investigative Dermatology, 1999
- Biosynthetic Processing of neu Differentiation FactorJournal of Biological Chemistry, 1995